News

This accelerated approval of Afinitor is based on an open-label, single-arm, 28-patient study conducted by Cincinnati Children’s Hospital Medical Center. The effectiveness of Afinitor is based on an

According to Roche, the EC approval is based on the results from the phase III Prima study which demonstrated that continuing MabThera for two years (maintenance treatment) in

Caraco Pharma has posted a net loss of $1.51m for the second quarter 2010, or $0.04 loss per diluted share, compared to net income of $6.67m, or $0.16

Dyadem claimed that it has expanded in response to a surge in customer demand in the EU for its enterprise risk management software and services amid heightened scrutiny

Prior to joining Medivir, Edenius served as senior vice president and chief scientific officer of Swedish pharmaceutical company Orexo. Edeniuss has also worked as the vice president and

Sufentanil TDS is a matrix-type transdermal patch with the active ingredient sufentanil, a highly potent opioid analgesic that is used as an injection or infusion for anesthesia and

CTI said that the application submission follows a positive opinion from the EMA’s Pediatric Committee (the PDCO), where PDCO agreed to CTI’s Pediatric Investigation Plan (PIP) for Pixuvri.

The safety and effectiveness of Teflaro was evaluated in four, Phase 3 clinical trials in patients ages 18 years and older (two each in CABP and in ABSSSI).

Valino served as an operating partner with Advent International, a global private equity firm, where he focused on investment opportunities in the Latin American health care industry. From